Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Maintenance therapy in non-small cell lung cancer.
Genestreti G, Di Battista M, Cavallo G, Bartolotti M, Brandes AA. Genestreti G, et al. Among authors: bartolotti m. Expert Rev Anticancer Ther. 2015;15(7):839-46. doi: 10.1586/14737140.2015.1052410. Epub 2015 May 31. Expert Rev Anticancer Ther. 2015. PMID: 26027675 Review.
The role of systemic and targeted therapies in brain metastases.
Franceschi E, Bartolotti M, Poggi R, Di Battista M, Palleschi D, Brandes AA. Franceschi E, et al. Among authors: bartolotti m. Expert Rev Anticancer Ther. 2014 Jan;14(1):93-103. doi: 10.1586/14737140.2014.856760. Epub 2013 Nov 26. Expert Rev Anticancer Ther. 2014. PMID: 24308678 Review.
Resistance to antiangiogenic therapies.
Bartolotti M, Franceschi E, Poggi R, Tosoni A, Di Battista M, Brandes AA. Bartolotti M, et al. Future Oncol. 2014 Jun;10(8):1417-25. doi: 10.2217/fon.14.57. Future Oncol. 2014. PMID: 25052752 Review.
The effect of re-operation on survival in patients with recurrent glioblastoma.
Franceschi E, Bartolotti M, Tosoni A, Bartolini S, Sturiale C, Fioravanti A, Pozzati E, Galzio R, Talacchi A, Volpin L, Morandi L, Danieli D, Ermani M, Brandes AA. Franceschi E, et al. Among authors: bartolotti m. Anticancer Res. 2015 Mar;35(3):1743-8. Anticancer Res. 2015. PMID: 25750337
Bevacizumab in recurrent glioblastoma: open issues.
Franceschi E, Bartolotti M, Brandes AA. Franceschi E, et al. Among authors: bartolotti m. Future Oncol. 2015 Oct;11(19):2655-2665. doi: 10.2217/fon.15.125. Epub 2015 Sep 11. Future Oncol. 2015. PMID: 26357999
35 results